Roger S. McIntyre
Papers
1
Total Citations
21
H-Index
1
About
Roger S. McIntyre is a leading figure in the psychopharmacology of mood disorders, with a particular focus on major depressive disorder (MDD) and bipolar disorder. His research has fundamentally reshaped how clinicians understand and treat these conditions, emphasizing the role of inflammation, metabolic comorbidity, and cognitive dysfunction. McIntyre’s work has been instrumental in advancing the concept of “functioning” as a key treatment outcome, moving beyond mere symptom reduction. He has authored over 900 peer-reviewed papers, amassing more than 80,000 citations, a testament to his profound influence. Notably, he has been a driving force in the development and clinical application of novel antidepressants, including the glutamatergic agent esketamine, and has extensively characterized the bidirectional relationship between mood disorders and diabetes. As a Professor of Psychiatry and Pharmacology at the University of Toronto, and Head of the Mood Disorders Psychopharmacology Unit, McIntyre’s research continues to set the global standard for evidence-based treatment, bridging the gap between neuroscience and clinical practice.
Research Focus
Key Achievements
Top Papers
- 1